Malaria treatment shown to be 100% effective in Phase 2 trial
A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days, according to the results of a Phase 2 clinical trial. The results of the trial were published Thursday (Aug. 26) in the Journal of Experimental Medicine. The trial shows that the addition of the drug Imatinib to the customary malaria therapy enables clearance of all malaria parasites from 90% of patients within 48 hours and from 100% of patients within three days, says Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of
